Bayer AG’s Werner Baumann, who will take over as chief executive in the next month, signaled his plans to beef up the company’s smallest unit -- animal health -- with acquisitions and partnerships.
“We would really, really like to strengthen our animal health business,” Baumann told reporters at a briefing in Leverkusen, Germany, where the company is based. “The animal health business is a business that, for many years, we have been trying to start, to start strategically, which means inorganically, that is still our goal.”
